Home › Cardiovascular Disease › Nebraska
Cardiovascular Disease clinical trials in Nebraska
10 studies for Cardiovascular Disease are looking for participants at sites in Nebraska.
Cities in Nebraska
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- CHI Health Nebraska Heart, Grand Island
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
- and 1 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Product Surveillance Registry
- Omaha
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Fremont
- Clinical Trial Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Nebraska Medical Center, Omaha
- Omaha VA Medical Center, Omaha
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Elkhorn
- Research Site, Fremont
- Research Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Bryan Heart, Lincoln
- Physician Research Collaboration, LLC, Lincoln
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT05931276From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.